Maria Walczak

1.6k total citations
81 papers, 1.2k citations indexed

About

Maria Walczak is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Maria Walczak has authored 81 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Pharmacology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Maria Walczak's work include Neuroscience and Neuropharmacology Research (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). Maria Walczak is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). Maria Walczak collaborates with scholars based in Poland, United States and France. Maria Walczak's co-authors include Stefan Chłopicki, Agnieszka Zakrzewska, Agnieszka Kij, Agnieszka Jasztal, Joanna Suraj, Kamil Kuś, Dorota Pawlik, Ryszard Lauterbach, Anna Kurpińska and Michael P. Sherman and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Maria Walczak

76 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Walczak Poland 20 415 177 132 123 122 81 1.2k
Neife Aparecida Guinaim dos Santos Brazil 24 545 1.3× 292 1.6× 106 0.8× 112 0.9× 139 1.1× 53 2.1k
Na Yang China 21 544 1.3× 147 0.8× 142 1.1× 114 0.9× 153 1.3× 120 1.4k
Rania M. Abdelsalam Egypt 24 504 1.2× 170 1.0× 214 1.6× 171 1.4× 109 0.9× 57 1.5k
Ana I. Casas Netherlands 18 823 2.0× 148 0.8× 257 1.9× 96 0.8× 103 0.8× 38 1.8k
Hsiu‐Chung Ou Taiwan 25 549 1.3× 221 1.2× 245 1.9× 83 0.7× 62 0.5× 41 1.5k
Lan Sun China 25 598 1.4× 132 0.7× 208 1.6× 55 0.4× 155 1.3× 66 1.6k
Nádia Maria Martins Brazil 16 398 1.0× 169 1.0× 72 0.5× 77 0.6× 92 0.8× 18 1.5k
Duen‐Suey Chou Taiwan 26 584 1.4× 364 2.1× 125 0.9× 68 0.6× 61 0.5× 60 1.9k
Dalaal M. Abdallah Egypt 22 523 1.3× 144 0.8× 221 1.7× 216 1.8× 68 0.6× 75 1.6k
Qiong Yuan China 23 724 1.7× 147 0.8× 247 1.9× 53 0.4× 81 0.7× 59 1.6k

Countries citing papers authored by Maria Walczak

Since Specialization
Citations

This map shows the geographic impact of Maria Walczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Walczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Walczak more than expected).

Fields of papers citing papers by Maria Walczak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Walczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Walczak. The network helps show where Maria Walczak may publish in the future.

Co-authorship network of co-authors of Maria Walczak

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Walczak. A scholar is included among the top collaborators of Maria Walczak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Walczak. Maria Walczak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kij, Agnieszka, Anna Bar, Kamil Przyborowski, et al.. (2024). Vascular protein disulfide isomerase A1 mediates endothelial dysfunction induced by angiotensin II in mice. Acta Physiologica. 240(4). e14116–e14116. 3 indexed citations
2.
Brzózka, Krzysztof, et al.. (2024). Physiologically based pharmacokinetic modeling of CYP2C8 substrate rosiglitazone and its metabolite to predict metabolic drug-drug interaction. Drug Metabolism and Pharmacokinetics. 57. 101023–101023.
3.
Andrianov, V. G., Илона Домрачева, Magdalena Milczarek, et al.. (2023). Aromatic sulphonamides of aziridine-2-carboxylic acid derivatives as novel PDIA1 and PDIA3 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2158187–2158187. 5 indexed citations
4.
Panek, Dawid, Anna Pasieka, Gniewomir Latacz, et al.. (2023). Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies. European Journal of Medicinal Chemistry. 249. 115135–115135. 9 indexed citations
5.
Marcinkowska, Monika, Barbara Mordyl, Agata Siwek, et al.. (2022). Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression. European Journal of Medicinal Chemistry. 247. 115071–115071. 10 indexed citations
6.
Zagórska, Agnieszka, Adam Bucki, Anna Partyka, et al.. (2022). Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia. European Journal of Medicinal Chemistry. 233. 114218–114218. 5 indexed citations
7.
Wichur, Tomasz, Justyna Godyń, Gniewomir Latacz, et al.. (2021). Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties. European Journal of Medicinal Chemistry. 225. 113792–113792. 19 indexed citations
8.
Kij, Agnieszka, Anna Bar, Kamil Przyborowski, et al.. (2021). Thrombin Inhibition Prevents Endothelial Dysfunction and Reverses 20-HETE Overproduction without Affecting Blood Pressure in Angiotensin II-Induced Hypertension in Mice. International Journal of Molecular Sciences. 22(16). 8664–8664. 6 indexed citations
9.
Niedzielska, Ewa, Lucyna Pomierny-Chamioło, Maria Walczak, et al.. (2021). Cocaine use disorder: A look at metabotropic glutamate receptors and glutamate transporters. Pharmacology & Therapeutics. 221. 107797–107797. 31 indexed citations
10.
Kamiński, Krzysztof, Szczepan Mogilski, Michał Abram, et al.. (2020). KA‐104, a new multitargeted anticonvulsant with potent antinociceptive activity in preclinical models. Epilepsia. 61(10). 2119–2128. 11 indexed citations
11.
Canale, Vittorio, Katarzyna Grychowska, Rafał Kurczab, et al.. (2020). A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties. European Journal of Medicinal Chemistry. 208. 112765–112765. 18 indexed citations
12.
Kurpińska, Anna, Joanna Suraj, Agnieszka Zakrzewska, et al.. (2019). Proteomic characterization of early lung response to breast cancer metastasis in mice. Experimental and Molecular Pathology. 107. 129–140. 30 indexed citations
13.
14.
15.
Kuś, Kamil, Edyta Kuś, Agnieszka Zakrzewska, et al.. (2017). Differential effects of liver steatosis on pharmacokinetic profile of two closely related hepatoselective NO-donors; V-PYRRO/NO and V-PROLI/NO. Pharmacological Reports. 69(3). 560–565. 3 indexed citations
16.
Oszczapowicz, Irena, et al.. (2017). Effects of structural modification of the daunosamine moiety of anthracycline antibiotics on pKa values determined by capillary zone electrophoresis. Journal of Chromatography B. 1060. 44–52. 13 indexed citations
17.
Kuś, Kamil, Agnieszka Zakrzewska, Małgorzata Szafarz, et al.. (2015). Validation of LC/MS/MS method for assessment of the in vitro activity of the selected rat cytochrome P450 isoenzymes - application to early drug metabolism screening. Jagiellonian University Repository (Jagiellonian University). 1 indexed citations
18.
Walczak, Maria. (2014). LC-MS/MS METHOD FOR SIMULTANEOUS QUANTIFICATION OF SERIES OF AMINOPROPAN-2-OL DERIVATIVES-APPLICATION TO IN VIVO PHARMACOKINETIC STUDY. Journal of Liquid Chromatography & Related Technologies. 37(16). 2233–2248. 2 indexed citations
19.
Pawlik, Dorota, et al.. (2013). Fish‐Oil Fat Emulsion Supplementation Reduces the Risk of Retinopathy in Very Low Birth Weight Infants. Journal of Parenteral and Enteral Nutrition. 38(6). 711–716. 104 indexed citations
20.
Hubicka, Urszula, et al.. (2012). Kinetic and thermodynamic studies of moxifloxacin hydrolysis in the presence and absence of metal ions in acidic solutions.. PubMed. 69(1). 59–31. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neife Aparecida Guinaim dos Santos Breakdown of academic impact, for papers by Na Yang Breakdown of academic impact, for papers by Rania M. Abdelsalam Breakdown of academic impact, for papers by Ana I. Casas Breakdown of academic impact, for papers by Hsiu‐Chung Ou Breakdown of academic impact, for papers by Lan Sun Breakdown of academic impact, for papers by Nádia Maria Martins Breakdown of academic impact, for papers by Duen‐Suey Chou Breakdown of academic impact, for papers by Dalaal M. Abdallah Breakdown of academic impact, for papers by Qiong Yuan
Rankless by CCL
2026